Form 4 · Filed Jun 2, 2026, 08:30 PM UTC
KNSA/Kiniksa Pharmaceuticals International, plc
BAKER BROS. ADVISORS LP — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 29, 2026 | A | other | 6,078 | $0 | — | 143,277 |
| May 29, 2026 | A | other | 6,078 | $0 | — | 2,744,894 |
| May 29, 2026 | A | other | 36,474 | — | — | 36,474 |
| May 29, 2026 | A | other | 36,474 | — | — | 36,474 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-253615